NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

They acquired his company and IP. It was a developed product. He stayed on since mid-2020, a few years, and likely continued to consult if they need him. This is nothing unusual for the founder of an acquired company to move on after such a period and it is not a “death”, he likely remains available on a consulting basis. Much of his compensation was in shares, so doubtful he would not continue to have an interest in the firms success especially since that will affect his reputation going forward for future projects, that he handed over a great product that led to the success of the acquiring company.